Ameriprise’s Inventiva IVA Stock Holding History

Ameriprise’s Portfolio IVA Stock Details IVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.69M	Buy	844,215 +228,742	+37%	+$1.39M	﹤0.01%	2470
2025 Q4	$2.86M	Buy	+615,473	New	+$2.86M	﹤0.01%	2809

Other funds holding IVA

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCP

SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Ameriprise's IVA Position: Q1 2026 in Review

Ameriprise increased its Inventiva (IVA) stake by 37% in Q1 2026, buying an estimated $1.39M and bringing the position to 844,215 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2470.

Ameriprise first reported a position in IVA in Q4 2025 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold IVA as of Q1 2026.

Ameriprise held 844,215 shares of Inventiva worth $4.69M as of Q1 2026.
Ameriprise bought 228,742 Inventiva shares in Q1 2026, an estimated $1.39M.
Inventiva made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2470 holding.
Ameriprise first reported a position in Inventiva in Q4 2025 and has held it in 2 quarters since.
65 funds tracked by Wall St. Rank held Inventiva as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.